Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization

NCT07304102 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT07304102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07304102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 31, 2032
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aorto iliac aneurysm, common iliac artery aneurysm